Q&A: Scientists behind Baby KJ’s custom CRISPR drug are planning to help more children news2025-10-08T18:29:20+00:00October 8th, 2025|Endpoints News|
Lexeo eyes faster path to approval for Friedreich’s ataxia gene therapynews2025-10-07T14:45:24+00:00October 7th, 2025|Endpoints News|
Cell therapy CDMO Mytos unveils its first facility in the UK news2025-10-06T12:00:45+00:00October 6th, 2025|Endpoints News|
Arbor partners with Chiesi Group in gene editing dealnews2025-10-06T11:00:11+00:00October 6th, 2025|Endpoints News|
Gene therapy startup launches with $11M to tackle aging disease of the eyenews2025-10-02T11:00:20+00:00October 2nd, 2025|Endpoints News|
Galapagos says it’s weeks away from decision on cell therapy business reviewnews2025-10-02T01:59:11+00:00October 2nd, 2025|Endpoints News|
Opus says gene therapy for ultra-rare disease boosted vision in teensnews2025-09-30T11:00:13+00:00September 30th, 2025|Endpoints News|
Patient groups push abandoned rare disease gene therapy toward clinical trialnews2025-09-26T14:32:48+00:00September 26th, 2025|Endpoints News|
Biogen calls it quits on AAV gene therapy, againnews2025-09-25T18:33:19+00:00September 25th, 2025|Endpoints News|
